ATP1A2 Gene Alternating hemiplegia of childhood type 1 Genetic Test sale cost 4400 AED
DHH Gene 46XY gonadal dysgenesis partial with minifascicular neuropathy Genetic Test sale cost 4400 AED DHH Gene 46XY gonadal dysgenesis partial with minifascicular neuropathy Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
APP Gene Alzheimer disease type 1 Genetic Test sale cost 4400 AED APP Gene Alzheimer disease type 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

ATP1A2 Gene Alternating hemiplegia of childhood type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ATP1A2 gene is associated with Alternating Hemiplegia of Childhood type 1 (AHC1), a rare neurological disorder characterized by recurrent episodes of hemiplegia (paralysis of one side of the body) that can alternate from one side to the other. Symptoms often manifest in infancy or early childhood and can include a wide range of other neurological issues, such as developmental delay, seizures, and abnormalities in movements. The ATP1A2 gene encodes an essential enzyme for maintaining the proper balance of sodium and potassium ions in nerve cells, crucial for normal brain function.

A genetic test for mutations in the ATP1A2 gene can confirm a diagnosis of Alternating Hemiplegia of Childhood type 1. This test is particularly valuable for affected individuals and their families for several reasons. Firstly, it provides a definitive diagnosis, helping to guide treatment and management strategies. Secondly, it offers information on the genetic basis of the condition, which can be useful for understanding the risk of recurrence in future pregnancies.

In the United Arab Emirates, DNA Labs UAE offers a genetic test for the ATP1A2 gene, catering to individuals who might be showing symptoms of AHC1 or have a family history of the disorder. The cost of the test is 4400 AED. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for mutations in the ATP1A2 gene. The results from this test can provide critical insights for families and healthcare providers, enabling informed decisions about care and support for individuals with AHC1.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 Genetic Test

Are you or a loved one experiencing repeated episodes of paralysis on one or both sides of the body? It could be a sign of Alternating Hemiplegia of Childhood (AHC) type 1, a rare neurological disorder. At DNA Labs UAE, we offer the ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 Genetic Test to help diagnose and manage this condition.

Test Components

The ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 Genetic Test includes:

  • NGS Technology
  • Neurological Disorders Test Type
  • Genetics Test Department

Price

The cost of the ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 Genetic Test is AED 4400.0.

Sample Condition

We accept the following sample conditions for this test:

  • Blood
  • Extracted DNA
  • One drop of blood on FTA Card

Report Delivery

You can expect to receive your test report within 3 to 4 weeks.

Method

We utilize NGS (Next Generation Sequencing) technology to analyze the ATP1A2 gene for mutations associated with AHC type 1.

Test Type

The ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 Genetic Test is specifically designed for neurological disorders.

Doctor

Your test will be overseen by a Neurologist.

Test Department

This test is conducted by our Genetics Test Department.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who will be undergoing the ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 NGS Genetic DNA Test. Additionally, a Genetic Counseling session will be conducted to draw a pedigree chart of family members affected with AHC type 1. This information is crucial for accurate diagnosis and management of the condition.

Test Details

The ATP1A2 gene is associated with Alternating Hemiplegia of Childhood (AHC) type 1, a rare genetic disorder that affects the nervous system. This condition leads to repeated episodes of paralysis on one or both sides of the body. Our NGS genetic testing can analyze the ATP1A2 gene for mutations that may cause AHC type 1. This test can help diagnose individuals with symptoms and can also be used for carrier testing in family members of affected individuals. Early diagnosis and treatment are essential for managing symptoms and improving the quality of life for those with AHC type 1. Furthermore, this genetic test provides important information for family planning and reproductive decision-making.

Test Name ATP1A2 Gene Alternating hemiplegia of childhood type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ATP1A2 Gene Alternating hemiplegia of childhood type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATP1A2 Gene Alternating hemiplegia of childhood type 1
Test Details

The ATP1A2 gene is associated with a rare neurological disorder called Alternating Hemiplegia of Childhood (AHC) type 1. AHC is a rare genetic disorder that affects the nervous system and causes repeated episodes of paralysis on one or both sides of the body.

NGS (Next Generation Sequencing) genetic testing can be used to analyze the ATP1A2 gene for mutations that may cause AHC type 1. This type of genetic testing can help diagnose AHC in individuals with symptoms and can also be used for carrier testing in family members of affected individuals.

Early diagnosis and treatment can help manage symptoms and improve quality of life for individuals with AHC type 1. Genetic testing can also provide important information for family planning and reproductive decision-making.

SKU: TEST-1029 Category:

Related products